ArticleJournal of oncology2020

Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting.

Brianna Lauren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.